kremezin

Small moleculeexperimental

Clinical trial activity

22 trials · 32 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
10
Phase 3
4
Phase 4
9

Earliest trial started Apr 1, 2004 (NCT00456859)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ast 120
  • ast-120
  • ast-120
  • kremezin
  • kremezin
  • renamezin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07182422Phase 4Sep 15, 2025Chang Gung University, ConMed Corporation
NCT04639674N/AJul 2, 2020Chang Gung University, ConMed Corporation, Government of Taiwan, Kaohsiung Medical University, Taichung Veterans General Hospital, Taipei Buddhist Tzu Chi Medical Foundation, Tung's Taiching MetroHarbor Hospital, Tzu Chi University
NCT03788252Phase 4Nov 23, 2018Cha Medical University
NCT02693613Phase 1Feb 1, 2016Astellas, FibroGen
NCT02687841Phase 3Jan 1, 2016Chang Gung University, China Medical University, National Taiwan University, Taipei Medical University, Taoyuan General Hospital
NCT02681991Phase 4Jan 1, 2016Daewon Pharmaceutical Co., Ltd., Yonsei University
NCT02681952Phase 4Dec 1, 2015Daewon Pharmaceutical Co., Ltd., Yonsei University
NCT01458652Phase 4Jan 1, 2011Lim Paik Seong, Tung's Taiching MetroHarbor Hospital
NCT01157260Phase 4Sep 1, 2010Ewha Womans University
NCT00867698Phase 2Mar 1, 2009Ocera Therapeutics
NCT00860431Phase 4Mar 1, 2009CJ HealthCare Corp., Kureha Corporation, Seoul National University
NCT01681303Phase 4Jan 1, 2009Chang Gung University
NCT00719758Phase 1Jun 1, 2008Astellas, Toray Industries, Inc
NCT00587275Phase 2Oct 1, 2007Department of Veteran Affairs, Ocera Therapeutics
NCT00558038Phase 2Sep 1, 2007Ocera Therapeutics, Scripps
NCT00583128Phase 2Aug 1, 2007Katholieke Universiteit Leuven, Ocera Therapeutics
NCT00500682Phase 3Jul 1, 2007Kureha Corporation, Mitsubishi Tanabe
NCT00501046Phase 3Jul 1, 2007Kureha Corporation, Mitsubishi Tanabe
NCT00583531Phase 2Mar 1, 2007Mayo Clinic, Ocera Therapeutics
NCT00583076Phase 2Feb 1, 2007Ocera Therapeutics, University of Rochester
Showing 20 of 22 trials
Page 1 / 2

Organizations

Research & Development (32)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Ocera TherapeuticsFor profit7722006
Chang Gung UniversityAcademic/Hospital4232009
Kureha CorporationFor profit3022007
AstellasFor profit2212008
ConMed CorporationFor profit2122020
Daewon Pharmaceutical Co., Ltd.For profit2212015
Mitsubishi TanabeFor profit2212007
Tung's Taiching MetroHarbor HospitalAcademic/Hospital2122011
Yonsei UniversityAcademic/Hospital2012015
Cha Medical UniversityAcademic/Hospital1112018
China Medical UniversityAcademic/Hospital1012016
CJ HealthCare Corp.For profit1012009
Department of Veteran AffairsGovernment1012007
Ewha Womans UniversityAcademic/Hospital1112010
FibroGenFor profit1012016
Government of TaiwanGovernment1012020
Institute for Health Outcomes and Process Evaluation ReseachAcademic/Hospital1112004
Jichi Medical UniversityAcademic/Hospital1012004
Kaohsiung Medical UniversityAcademic/Hospital1012020
Katholieke Universiteit LeuvenAcademic/Hospital1012007
32 organizations
Page 1 / 2